The future of chronic pain medicines starts with collaborative research
At Cellen Therapeutics we believe that collaborating is key to accelerate healthcare for chronic pain management. Our team have joined forces with experts in healthcare, business and research. We aim to effectively impact the lives of patients and further knowledge in bespoke medications, such as cannabinoid-based medicines.
​
​
Building technology to support a new era of therapeutics
Our MedCanHub is a platform developed by NHS consultants, to increase the proficiency and confidence of doctors to prescribe in the UK.
​
The platform is available to use for free by GMC registered doctors and GPhC registered pharmacists.
The MedCanHub supports clinical teams with tools such as:
-
Contraindications checklist
-
A literature review of validated dosage of THC and CBD.
-
Consultation checklist
-
Guidance on how to write Medical Cannabis prescriptions and how to get them fulfilled in the UK.
-
Letter creation tool
-
Links to online training, regulations and guidelines.
We work with industry leaders
Cellen Therapeutics’ personalised Cannabis-based Medicinal Products are manufactured in the UK by our partners using only pharmaceutical grade ingredients, and robustly tested in independent laboratories.
Our expert team members sit on the advisory councils for UK based advocacy & collaboration groups
